Deciphera Pharmaceuticals | Company Profile, Culture & Jobs

Company overview

As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

Founded in 2003

Waltham, Massachusetts, USA

511 employees (17 in marketing)

www.deciphera.com

92% recommend to a friend

89% positive business outlook

People

Marketing leadership

Craig Laferty

Sr. Director, Hematology Marketing

At the company for 4 months

Taylor Harris

Senior Manager, Brand Marketing

At the company for 1 year 1 month

Headcount trend

Company growth over the last 12 months

Funding

Total funding

$1B

Last raise

$125M

Post IPO Equity, 3 years ago

Funding history

Jan 2023

Post IPO Equity Deciphera Pharmaceuticals · $125M

Apr 2022

Post IPO Equity Deciphera Pharmaceuticals · $172.5M

Aug 2019

Post IPO Equity Deciphera Pharmaceuticals · $400M

Jun 2018

Post IPO Equity Deciphera Pharmaceuticals · $172M

Jun 2017

Series C Deciphera Pharmaceuticals · $52M

Audience

Monthly website visitors

9.9K

Month over month-18.1%

Quarter over quarter-35.9%

Top sourceSearch (47.4%)

Ad budget per month$0.0

Average search rank41.3

Traffic source mix

Search

47.4%

Direct

40.3%

News

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Dec 6, 2025 • Business Wire

Deciphera Announces the Opening of a New Office in Zug, Switzerland

Nov 17, 2025 • Business Wire

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025

Nov 12, 2025 • Business Wire

Links

www.deciphera.com

Crunchbase

X (Twitter)

Glassdoor

Deciphera Pharmaceuticals insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2003

Headquarters

Waltham, Massachusetts

Employees

201-500

14.3% growth last 12mo

Marketing team

17

3% of company

20 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Late-stage · Growing 14.3% last 12 months · More mature · Last funding 3+ years ago

Trend

2021-06-28 -> 2026-02-09

Headcount (12 months)

+14.3%

Last funding round

38 months ago

Negative news (120 days)

0

Risk score1/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.9K

Month over month-18.1%

Quarter over quarter-35.9%

Top sourceSearch (47.4%)

Traffic source mix

Search

47.4%

Direct

40.3%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

10 competitor sites

Search traffic: 609 organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

+46

Ad budget per month

$0.0

Average search rank

41.3

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Marketing team size

Shows saved marketing team size.

17

3% of the company • 20 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 17.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

4.3 / 5

Work-life balance

4.4 / 5

Culture

4.6 / 5

Diversity & inclusion

4.3 / 5

Recommend to a friend

92%

Positive business outlook

89%

Funding

Shows saved funding data.

Total funding

$1B

Last raise

Post IPO Equity

3 years ago

Funding details

Amount raised

$1B

Last round

Post IPO Equity

Last fundraise

3 years ago

News

Shows saved company news.

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Dec 6, 2025 • Business Wire

Deciphera Announces the Opening of a New Office in Zug, Switzerland

Nov 17, 2025 • Business Wire

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025

Nov 12, 2025 • Business Wire

Loading insights...

Headcount +14.3% year over year

Jan 2016

Series B Deciphera Pharmaceuticals · $15M

Social

5.4%

Referral

5.4%

Paid referral

1.3%

LinkedIn followers

Follower count and growth

Total followers

65.7K

12-mo growth

+31.6%

Monthly growth

+1.8%

Salaries

Typical salary range

$165,500 – $228,500

/ yr

Median base

$183,000

Median total

$183,000

Median experience

9 years

Submissions

4

Help build salary transparency at Deciphera Pharmaceuticals

Share your compensation anonymously to see full data.

Contribute

Open positions9 open marketing positions

Associate Director, Marketing – Romvimza

Deciphera Pharmaceuticals

Waltham, MA (On-site)

$174K/yr - $239K/yrIn-houseFull-timeSenior level10+ years exp.

3 weeks ago

Senior Manager, Marketing Operations

Deciphera Pharmaceuticals

Waltham, MA (On-site)

$130K/yr - $179K/yrIn-houseFull-timeSenior level8+ years exp.

3 weeks ago

Senior Manager, Marketing Operations

Deciphera Pharmaceuticals

Waltham, MA (Hybrid)

$130K/yr - $179K/yrIn-houseFull-timeSenior level8+ years exp.

3 weeks ago

Associate Director, Brand Marketing (Hematology)

Deciphera Pharmaceuticals

Waltham, MA (Hybrid)

$174K/yr - $239K/yrIn-houseFull-timeSenior level10+ years exp.

6 weeks ago

Associate Director, Brand Marketing (Hematology)

Deciphera Pharmaceuticals

Waltham, MA (Hybrid)

$174K/yr - $239K/yrIn-houseFull-timeSenior level10+ years exp.

6 weeks ago

Senior Manager, Marketing Operations

Deciphera Pharmaceuticals

Waltham, MA (Hybrid)

$130K/yr - $179K/yrIn-houseFull-timeSenior level8+ years exp.

6 weeks ago

View all 9 jobs

Deciphera Pharmaceuticals insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2003

Headquarters

Waltham, Massachusetts

Employees

201-500

14.3% growth last 12mo

Marketing team

17

3% of company

20 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Late-stage · Growing 14.3% last 12 months · More mature · Last funding 3+ years ago

Trend

2021-06-28 -> 2026-02-09

Headcount (12 months)

+14.3%

Last funding round

38 months ago

Negative news (120 days)

0

Risk score1/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.9K

Month over month-18.1%

Quarter over quarter-35.9%

Top sourceSearch (47.4%)

Traffic source mix

Search

47.4%

Direct

40.3%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

10 competitor sites

Search traffic: 609 organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

+46

Ad budget per month

$0.0

Average search rank

41.3

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Marketing team size

Shows saved marketing team size.

17

3% of the company • 20 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 17.

Glassdoor ratings

Shows saved Glassdoor ratings.

Glassdoor ratings

Overall rating

4.3 / 5

Work-life balance

4.4 / 5

Culture

4.6 / 5

Diversity & inclusion

4.3 / 5

Recommend to a friend

92%

Positive business outlook

89%

Funding

Shows saved funding data.

Total funding

$1B

Last raise

Post IPO Equity

3 years ago

Funding details

Amount raised

$1B

Last round

Post IPO Equity

Last fundraise

3 years ago

News

Shows saved company news.

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting

Dec 6, 2025 • Business Wire

Deciphera Announces the Opening of a New Office in Zug, Switzerland

Nov 17, 2025 • Business Wire

Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025

Nov 12, 2025 • Business Wire

Social

5.4%

Referral

5.4%

Paid referral

1.3%

Total followers

65.7K

12-mo growth

+31.6%

Monthly growth

+1.8%